Overview
Hirotaka Masuda practices practicing medicine in Chuo, Japan.
Their clinical expertise encompasses Myelomeningocele, Endometriosis, Infertility, and Premature Ovarian Failure.
They are actively involved in clinical research, co-authoring 29 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Hirotaka Masuda
Is Hirotaka Masuda a top-rated expert for Myelomeningocele?
MediFind is an objective health platform that identifies experts based on real-world data. Hirotaka Masuda is classified as an Experienced expert for Myelomeningocele, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Hirotaka Masuda participate in research or clinical trials?
Yes. Hirotaka Masuda has published 29 articles and abstracts on conditions like Myelomeningocele. You can view a list of Hirotaka Masuda's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- EndometriosisMasuda isExperienced. Learn about Endometriosis.
- InfertilityMasuda isExperienced. Learn about Infertility.
- MyelomeningoceleMasuda isExperienced. Learn about Myelomeningocele.
- Premature Ovarian FailureMasuda isExperienced. Learn about Premature Ovarian Failure.